Based on publicly available proxy filings, SEC disclosures, and compensation data, Nate Gross, MD's estimated net worth falls in the range of $25 million to $45 million as of 2025. The most credible reference point comes from MarketScreener's insider profile, which pegs it at approximately $33 million based on tracked equity holdings. That figure aligns reasonably well with what we can independently piece together from his Doximity stock activity and executive compensation history. It is an estimate, not a certified financial disclosure, but it is grounded in real data rather than guesswork.
Nate Gross MD Net Worth: Estimated Range and How It’s Calculated
Marcus Holloway
4 May 2026
Who Nate Gross, MD Is (and Why That Shapes the Estimate)
Nate Gross is not a practicing internist seeing patients in a typical clinical role. He is a physician-entrepreneur who co-founded two significant healthcare companies. He graduated from Emory University School of Medicine (Class of 2010) and simultaneously earned an MBA from Harvard Business School (2009 to 2011). That combination set the trajectory for a career that blurs the line between medicine and venture-backed technology.
He co-founded Rock Health in 2010, one of the first dedicated digital health accelerators, alongside Halle Tecco. He then co-founded Doximity, the professional network for physicians that launched in 2011. At Doximity he held the title of Co-founder and Chief Strategy Officer, a role he held through roughly fiscal year 2025, when an SEC filing confirmed he stepped down from his operational role and transitioned to an independent advisory position under a consulting agreement effective June 17, 2025.
This background matters for a net worth estimate because the wealth here is not driven by clinical salary. It is driven by founder equity in a company that went public. Doximity's IPO in June 2021 was a significant liquidity event: the CEO Jeff Tangney became a billionaire overnight, and co-founders including Nate Gross held meaningful equity stakes. Understanding that context is the entire foundation of any credible estimate.
He has also received recognition including a San Francisco Business Times '40 Under 40' award, an NEJM Scholar designation, and a Dean's Award from Emory, markers that place him firmly in the upper tier of physician-entrepreneurs rather than in a typical clinical career path. That distinction matters when comparing him to peers like Anthony Youn, MD or Eric George, MD, who built wealth primarily through medical practice and media, rather than tech equity. For example, Anthony Youn’s net worth is often discussed in the same context of physician wealth and media versus tech equity Anthony Youn, MD.
What We Can Actually Verify
When it comes to net worth research, the most valuable thing you can do is separate confirmed facts from reasonable inferences. For Nate Gross, here is what is actually documented in public records.
Equity Activity and Executive Compensation
The Doximity 2025 Proxy Statement, filed with the SEC, includes a table of option exercises and shares vested for named executives. For Nate Gross, it shows 173,866 options exercised with a value realized of $6,577,979, plus 21,011 shares acquired on vesting with a value realized of $1,006,300. That is over $7.5 million in realized equity value in a single proxy reporting period. This is not an estimate; it is a disclosed figure from a regulatory document.
Salary.com, pulling from the same proxy data, reports his total fiscal year 2025 compensation at $1,520,444, broken down as: $322,917 in base salary, $198,000 in bonus, $994,201 in stock awards, and $5,326 in other compensation. This gives a reliable baseline for his annual income picture at Doximity before his transition to the advisor role.
Post-Departure Consulting Agreement
An SEC exhibit filed June 2025 documents a formal consulting agreement between Doximity, Inc. and Nate Gross, effective June 17, 2025. He is designated as an independent contractor providing advisory services. The specific compensation terms in the exhibit are not reproduced in available summaries, but the existence of an ongoing paid advisory relationship confirms he retained a financial connection to Doximity after stepping down from his officer role.
Career History and Education
His Doximity physician profile lists him as an Internal Medicine physician based in San Francisco, CA. His educational and professional credentials, including the Harvard MBA and Emory medical degree, are listed publicly on Doximity's leadership and CV pages. Rock Health's background, documented on its website and Wikipedia, confirms his founding role there as well.
How Doctors' Net Worth Is Estimated (and Why This Case Is Different)
For most physicians, net worth estimation follows a fairly predictable framework. The BLS reports median physician wages at $239,200 or more per year as of May 2024. Medscape's Physician Compensation Report provides specialty-level benchmarks. The Medscape 2026 Physician Wealth and Debt Report, summarized by Becker's ASC, finds that retirement accounts are the single largest driver of physician net worth, followed by real estate. For a physician 10 to 15 years into a high-earning specialty, a net worth between $1 million and $5 million would be typical, depending on debt repayment, savings rate, and asset allocation.
Nate Gross does not fit that template. His wealth driver is founder equity in a publicly traded company, not clinical salary accumulation. The standard physician wealth model is essentially irrelevant here; the right framework is more like a tech co-founder than an internist. The variables that matter are: how much equity he held at IPO, how much he retained or sold, the price of Doximity stock over time, and any other investment activity or income streams.
| Wealth Driver | Typical Physician | Nate Gross, MD |
|---|---|---|
| Primary income source | Clinical salary ($250K–$500K+) | Executive comp + equity ($1.5M+ in FY2025) |
| Largest asset class | Retirement accounts, real estate | Doximity equity (stock options + RSUs) |
| Liquidity events | Rare (practice sale) | IPO 2021, ongoing vesting, options exercises |
| Net worth range (peer group) | $1M–$5M (mid-career) | $25M–$45M (estimated) |
| Debt exposure | Student loans, mortgage | Likely minimal given income trajectory |
Estimated Net Worth Range and How We Get There
Putting together what is documented, a reasonable estimate for Nate Gross, MD's net worth in 2025 is $25 million to $45 million, with $30 million to $35 million being the most defensible central estimate. Here is how that breaks down.
- Realized equity (documented): The 2025 proxy alone shows over $7.5 million in realized value from options and RSU vesting. This is a single year and does not include equity activity from prior years, including the post-IPO period beginning in 2021.
- Remaining equity holdings: MarketScreener's insider tracker estimated his net worth at approximately $33 million as of September 2025, which is largely based on tracked share and option holdings. This number fluctuates with Doximity's stock price.
- Accumulated compensation: At over $1.5 million per year in total compensation for FY2025 alone, plus prior years as a co-founder and CSO, accumulated liquid savings and investments are likely substantial.
- Real estate and other assets: San Francisco-based, with over a decade of high income, real estate holdings are plausible but unverified. No public records confirm specific property holdings.
- Advisory income: The post-departure consulting agreement with Doximity suggests ongoing income, though the amount is not disclosed publicly.
- Debt and liabilities: No public information suggests significant debt. Student loans from medical school may have been long retired. No bankruptcy or lien records appear in available sources.
The $33 million figure from MarketScreener is the most specific published estimate and it is rooted in equity tracking rather than pure speculation. The range of $25 million to $45 million accounts for uncertainty about unrealized gains, private investments, real estate, and liabilities we cannot see. If Doximity's stock performs strongly, the upper end of that range becomes more plausible. If he has distributed or spent more of his equity than typical, the lower end applies.
Why Net Worth Numbers Online Often Disagree
If you search for net worth figures for physicians or tech-adjacent founders like Nate Gross, you will quickly run into wildly inconsistent numbers across sites. abner mares net worth. You can also find similar net worth figures for Kim Foster, MD by comparing how different sites handle disclosed compensation versus equity holdings Kim Foster, MD net worth. Some will cite $1 million, others $10 million, others nothing at all. Here is why that happens and how to weigh different sources.
- No mandatory public disclosure: Unlike public company CEOs who must disclose compensation in proxy statements, there is no requirement for anyone to publicly report total personal net worth. Every number you see on a net worth site is an estimate derived from indirect signals.
- Equity value changes constantly: Founder wealth tied to publicly traded stock moves with every trading day. A number that was accurate in June 2021 at Doximity's IPO peak is different from a number today. Sites that publish static figures without update dates are often stale.
- Methodology varies widely: Some sites count only tracked equity positions. Others add estimated salary, real estate, and lifestyle expenses. Without a disclosed methodology, two sites can reach wildly different numbers from the same underlying data.
- Confusion between similar names: There are multiple physicians named Nate or Nathan Gross. Figures intended for a different individual can attach to the wrong profile, especially on sites that aggregate data automatically.
- Private assets are invisible: Venture investments, private company stakes, savings accounts, and real estate are not publicly disclosed. Sites that only track equity holdings are showing you a floor, not a ceiling.
The MarketScreener estimate at $33 million is worth taking seriously precisely because it is based on tracked insider equity positions, which are the most systematically documented part of a founder's wealth. But it should still be treated as an estimate with real uncertainty bands around it, not a certified figure.
How to Check or Update This Estimate Yourself
If you want to do your own research or verify that this estimate is still current, here is exactly where to look and what to do with what you find.
- Check SEC EDGAR for Doximity filings: Go to sec.gov and search for Doximity (ticker: DOCS). Look at the most recent proxy statement (DEF 14A) for the section on 'Option Exercises and Stock Vested.' This will show you any realized equity value for Nate Gross in the most recent fiscal year.
- Check Form 4 filings: Insider transactions are reported on Form 4, which is filed with the SEC within two business days of a transaction. Search for 'Nate Gross' or 'Nathan Gross' under Doximity's insider filings to see any recent stock sales or acquisitions.
- Look at MarketScreener or similar insider trackers: Sites like MarketScreener and OpenInsider aggregate Form 4 data and provide a running estimate of insider holdings value. These update as new filings come in.
- Review the most recent proxy statement compensation table: Executive compensation tables in proxy filings show base salary, bonus, and stock awards for named executives. Even after his departure, any transitional compensation may appear.
- Cross-reference Doximity's stock price: If the MarketScreener estimate was calculated at a specific share price, you can adjust it proportionally if the stock has moved significantly since then. Doximity's stock history is freely available on any major financial data site.
- Search for new SEC exhibits: Consulting agreements and other arrangements with former executives are often filed as 8-K exhibits. Search EDGAR for Doximity 8-K filings dated after June 2025 to see if any updated compensation terms have been disclosed.
Net worth estimates for physician-entrepreneurs like Nate Gross require a different research approach than, say, looking up a celebrity's estimated earnings. The evidence trail is in SEC filings and proxy documents, not entertainment industry reports or social media. If you follow the steps above, you can build a more current and more accurate picture than any static net worth page will give you. If you are trying to locate the latest figure, searches for Eric George MD net worth can help you compare what different sources claim net worth page. Andrew Abraham, MD net worth research often follows the same pattern of looking at disclosed equity activity and compensation rather than relying on static third-party numbers. Treat the $25 million to $45 million range as a reasonable working estimate for today, with the understanding that it should be revisited if Doximity's stock moves materially or new filings emerge.
FAQ
Why do net worth figures for Nate Gross MD differ so much across websites?
Net worth estimates usually swing because Doximity shares and options can reprice, and because the estimate may include unrealized gains (paper value) versus only cash-equivalent realizations (what he sold). A good check is whether the most recent proxy or Form 4 filings show additional sales, dispositions, or new option grants that change the share count and cost basis.
What part of Nate Gross MD wealth comes from being a practicing doctor versus building companies?
In this case, the biggest driver is founder equity in Doximity, not ongoing physician salary. Even with disclosed base salary and stock awards for 2025, the estimate primarily depends on how many shares/options he held around the IPO, how much of that equity he exercised or sold later, and the current share price. Clinical income models for typical internists generally do not transfer well here.
Does the value realized in a proxy statement directly equal Nate Gross MD net worth?
The disclosed proxy numbers represent realized value during the reporting period (for example, the value realized from option exercises and the value realized from shares vested). They do not automatically equal total net worth, because net worth also depends on remaining holdings, unrealized gains or losses, and liabilities you cannot see in standard disclosures.
How can I verify whether the $25 million to $45 million range is still current?
Treat static net worth pages as outdated once there is a new SEC event. For a faster verification loop, look for Doximity proxy updates (for changes in compensation and equity activity) and insider transaction reports like Form 4 around sale or acquisition dates. If no new equity transactions appear, the estimate may still change due to market price moves.
Could lockups, vesting, or taxes make the net worth range inaccurate?
Yes, the equity-based range can be biased if sources assume the insider holdings are fully tradable and current. In reality, there may be vesting schedules, lockups, and tax-related selling patterns that affect how much of the equity is actually available as liquid wealth. The article’s range accounts for uncertainty, but it may understate or overstate depending on those practical constraints.
How should I adjust the estimate if I see new SEC insider sales or purchases?
A strong rule of thumb is to compare the central estimate to insider-tracking estimates, then widen or narrow the band based on specific changes. For example, if new filings show significant additional share sales, you would lean toward the lower end. If they show continued retention without sales and Doximity stock has risen, you would lean toward the upper end.
Why can’t we compute Nate Gross MD net worth exactly from public SEC filings?
No. Net worth is assets minus liabilities, but public records usually provide limited visibility into personal debts, loans, guarantees, and off-balance-sheet obligations. For founder-heavy profiles, investment volatility and leverage can also matter, so the same share price can translate into a different net worth depending on borrowing and spending.
What common mistake do people make when interpreting proxy equity tables?
In founder equity cases, stock awards, option exercises, and vested shares can be overlapping signals, not separate piles of money. An option exercise produces proceeds and tax impacts, while vested shares can later be sold or retained. The right approach is to use the disclosed realized figures for that period, then reconcile with remaining holdings implied by later transactions.
How can I sanity-check a third-party “net worth” number without deep finance modeling?
If you want a quick method to sanity-check any third-party net worth figure, compare it to (1) the scale of realized equity value in the latest proxy period, and (2) what that implies about remaining equity at current prices. If the third-party number assumes unrealistically large remaining holdings or ignores liquidation, it often conflicts with the disclosed exercise and vesting activity.
How often should I expect the net worth estimate for Nate Gross MD to change?
Yes. The net worth range is meant for 2025, but it can change quickly after fiscal-year proxies due to share price moves and subsequent sales. If you are using it for a decision or comparison, update the estimate after major stock moves or after the next insider disclosure cycle, not just once per year.
